The first "Future Star" Biopharmaceutical Innovation Transformation Project Competition was held in Beijing

The first "Future Star" Biopharmaceutical Innovation Transformation Project Competition, sponsored by the Beijing Municipal Science and Technology Commission, The Beijing Economic and Technological Development Zone Management Committee, the Chinese Academy of Medical Sciences and China Biopharmaceutical Co., Ltd., was held in Beijing on January 6, 2021.
48 projects from domestic universities, research institutes, hospitals and pharmaceutical enterprises entered the final evaluation stage of the competition, through experts and scholars from the Department of Science and Education of the National Health and Health Commission, Peking University College of Pharmacy, Capital Medical University, Institute of Pharmaceuticals of the Chinese Academy of Medical Sciences, Military Academy of Sciences, Shanghai Jiao Jiao university, China Pharmaceutical Enterprise Management Association, Beijing Ted Pharmaceuticals, San En Capital, Fuyu Asia Investment and other institutions and The rigorous review by professional investors, and finally, the "Innovative Drug Research for the Treatment of Idiofibromatics with Class 1 New Drug Atomod" project from the Institute of Pharmacology of the Chinese Academy of Medical Sciences, and the project "Behavioral and Brain Imaging Diagnostic System based on Autism Social Interaction Subtype and Percuttive Electrostimulation Individualization Therapy" from Peking University, respectively, won the first prize of the Biopharmaceutical Group and the Medical Device Group.
This contest is directed by China's top scientific research institutions, while inviting pharmaceutical enterprises, investment institutions and other projects to meet directly with the project team, aiming to explore the original, original, leading outstanding pharmaceutical innovation and technology projects, through the competition to build innovative drugs and medical devices from scientific research to industrialization of an important bridge, to promote innovative drugs and medical devices research and development technology flow and sharing results.
this contest to take the project team report, authoritative expert review, according to the project innovation point, the results of the transformation prospects, market prospects, investment value and other factors to evaluate.
the project will get the opportunity to meet face-to-face with industry authoritative experts and professional investment institutions, and get guidance from the key nodes of the evaluation tutor in the process of transformation and entrepreneurship, so as to promote the successful transformation of the project.
competition is divided into two categories: biomedicine and medical devices, respectively, the first, second and third prizes.
, the participating projects will be integrated into the Beijing Pharmaceutical Science and Technology Achievements Transformation Coordination and Service Platform Project Resource Bank, which provides science and Technology Achievements Transformation Services and industry chain-wide resource docking. At the closing ceremony of the
Competition, the project unit that won the first prize signed a on-site contract with the pharmaceutical research institute of the Chinese Academy of Medical Sciences and Beijing Ted Pharmaceutical Co., Ltd., which became the first seed project to be set up in the Beijing Pharmaceutical Science and Technology Achievements Transformation Coordination and Service Platform jointly built by the organizers.
Fellow Wang Chen: To improve the transformation of scientific and technological achievements into ecology, to help regional industrial upgrading and economic and social development Of the Chinese Academy of Medical Sciences, Beijing Concord Medical College, Vice President of the Chinese Academy of Engineering, Wang Chen academician pointed out that at the beginning of 2021, the new crown epidemic has made significant achievements, the form of anti-epidemic is still serious, how to promote the development of medicine, is the whole country and the nation should consider the issue.
"Future Star" Biopharmaceutical Innovation Transformation Project Competition focuses on both young people and early stage transformation, which is a very important meaning as "Future Star".
the presentation of outstanding achievements to investment institutions and enterprises through the form of innovation competitions will help the spillover of scientific and technological achievements of research institutions and universities, to the technological innovation and development of enterprises, and to the upgrading of regional industries and economic and social development.
Gu Jinhui: Actively engaged in scientific and technological innovation, improve the level of public health, the National Health and Health Commission, Deputy Director Gu Jinhui said that the current biomedical science and technology innovation in the national development strategy occupies an unprecedented height, the country continues to increase investment in scientific research, while constantly optimizing policies, improve the innovation environment, the vast number of scientific researchers should actively participate in scientific and technological innovation, especially original.
accelerate the transformation of scientific and technological achievements into real productivity at the same time, we can truly implement the scientific and technological innovation and development proposed by General Secretary Xi.
we must adhere to the fourth goal, face people's life and health, improve the health level of our people, practice the concept of the community of human destiny, and make our country's contribution to the health of the international people.
Liu Wei: Medical health and artificial intelligence is beijing's future industry "double engine" Beijing Science and Technology Commission Deputy Director Liu Wei said, science and technology innovation center is Beijing as the capital of the city's strategic positioning of one of the four centers, in the direction of innovation and development, push up the cutting-edge industry, medical health and artificial intelligence and other cutting-edge new technologies, as Beijing's future industry "double engine", with innovation to drive industrial structure upgrading, enhance the new economic status.
Hope that the organizers through the "Future Star" biomedical innovation achievements transformation project competition opportunities, give full play to The advantages of Beijing as an innovation center, and further stimulate research institutes and enterprises between the project cooperation, and effectively do a good job in scientific and technological innovation and innovation results of the transformation.
Chen Xiaonan: All-round whole process of service, create a better future for the development of biopharmaceutical industry Beijing Economic and Technological Development Zone Management Committee Chen Xiao male deputy director said that Ted Pharmaceuticals is focused on the international leading high-end targeted preparation technology and biopharmaceutical field of international well-known high-tech enterprises, but also the development zone's key enterprises, there are original research drugs, innovative drugs to high-end medical device research and development production, professional marketing to big data medical and other complete pharmaceutical industry chain.
The Institute of Pharmacy of the Chinese Academy of Medical Sciences, as the national team for drug research, has always adhered to the focus on innovative drugs, featuring natural products, applied basic research and innovative drug research and development, promoted the integration process of industry, science and research, and walked out of a new drug innovation path with Chinese characteristics.
The Chinese Academy of Medical Sciences and Ted Pharmaceuticals, is a deep integration of innovation, the first "Future Star" biopharmaceutical innovation transformation project competition selected high-quality seed projects, will enjoy the best policy support and government services in the open area.
Zheng Xiangling: To help the first-line scientific research team through the scientific and technological innovation process of the "last kilometer" of the contest co-sponsor - Beijing Ted Pharmaceutical Co., Ltd. Chairman Zheng Xiangling said that the transformation of scientific and technological achievements from one kind of innovation to another innovation, from laboratory and theoretical innovation to production lines and market innovation, from "bookshelf" to "shelf".
is the "last kilometer" in scientific and technological innovation, Ted Pharmaceuticals and the Chinese Academy of Medical Sciences Institute of Pharmacy jointly organized the "Future Star" biomedical innovation transformation project competition, the purpose is to give the innovative pharmaceutical team, love medicine people set up a platform, lift a car, help first-line researchers successfully walk the "last kilometer", hope that more than 40 contestants, whether or not won, can be indomitable spirit towards the goal of breaking the threshold of high-tech products, to achieve their dreams.
Jiang Jiandong: The transformation of pharmaceutical science and technology achievements to help the development of China's pharmaceutical science and technology development of this contest co-sponsor - the Chinese Academy of Medical Sciences Institute of Pharmaceutical Research Director Jiang Jiandong said that the Institute has always attached importance to the transformation of pharmaceutical science and technology achievements, from the older generation of pharmaceutical researchers, focus on the application of the results of medical science and technology research to serve the community.
years, in terms of technology transfer, has received a lot of support from the Beijing Municipal Government, helping many pharmaceutical enterprises to further develop.
hope that through the input of new technologies, in line with the development plan of Beijing Ted Pharmaceutical Company, to help it better serve the community.
The contest attracted a number of research units, universities, enterprises and investment institutions to participate in the pharmaceutical and medical device science and technology innovation exchanges, hoping that this contest can make the achievements of pharmaceutical science and technology innovation to further land, to help China's medical science and technology development.
collection